Nexplanon: the new implant for long-term contraception. A comprehensive descriptive review

References

• Graesslin O, Korver T. The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience. Eur J Contracept Reprod Health Care 2008;13 Suppl 1:4–12.
   PubMed Web of Science ®Google Scholar
• Harrison-Woolrych M, Hill R. Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia. Contraception 2005;71:306–308.
   PubMed Web of Science ®Google Scholar
• Jaffer K, Whalen S. Self removal of Implanon: a case report. J Fam Plann Reprod Health Care 2005;31:248.
   PubMedGoogle Scholar
• Gwinnell E. Expulsion of Implanon. J Fam Plann Reprod Health Care 2007;33:211.
   PubMedGoogle Scholar
• Mansour D. Nexplanon(®): what Implanon(®) did next. J Fam Plann Reprod Health Care 2010;36:187–189.
   PubMed Web of Science ®Google Scholar
• Sitruk-Ware R. New progestagens for contraceptive use. Hum Reprod Update 2006;12:169–178.
   PubMed Web of Science ®Google Scholar
• Sitruk-Ware R, Nath A. Metabolic effects of contraceptive steroids. Rev Endocr Metab Disord 2011;12:63–75.
   PubMed Web of Science ®Google Scholar
• Mäkäräinen L, van Beek A, Tuomivaara L, Asplund B, Coelingh Bennink H. Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant. Fertil Steril 1998;69:714–721.
   PubMed Web of Science ®Google Scholar
• Wenzl R, van Beek A, Schnabel P, Huber J. Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon. Contraception 1998;58:283–288.
   PubMed Web of Science ®Google Scholar
• Bennink HJ. The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant. Eur J Contracept Reprod Health Care 2000;5 Suppl 2:12–20.
   PubMedGoogle Scholar
• Díaz S, Pavez M, Moo-Young AJ, Bardin CW, Croxatto HB. Clinical trial with 3-keto-desogestrel subdermal implants. Contraception 1991;44:393–408.
   PubMed Web of Science ®Google Scholar
• Croxatto HB. Mechanisms that explain the contraceptive action of progestin implants for women. Contraception 2002;65:21–27.
   PubMed Web of Science ®Google Scholar
• Davies GC, Feng LX, Newton JR, Van Beek A, Coelingh-Bennink HJ. Release characteristics, ovarian activity and menstrual bleeding pattern with a single contraceptive implant releasing 3-ketodesogestrel. Contraception 1993;47:251–261.
   PubMed Web of Science ®Google Scholar
• Van den Bosch T, Donders GG, Riphagen I, Debois P, Ameye L, De Brabanter J, Van Huffel S, et al. Ultrasonographic features of the endometrium and the ovaries in women on etonogestrel implant. Ultrasound Obstet Gynecol 2002;20:377–380.
   PubMed Web of Science ®Google Scholar
• Varma R, Mascarenhas L. Endometrial effects of etonogestrel (Implanon) contraceptive implant. Curr Opin Obstet Gynecol 2001;13:335–341.
   PubMed Web of Science ®Google Scholar
• Lortlar N, Kilic S, Peker T, Zulfikaroglu E, Omeroglu S, Erbas D, Celik HH, et al. The long-term effects of progesterone-only contraceptives on endometrium and ovary in rats. Arch Gynecol Obstet 2010;281:1051–1059.
   PubMed Web of Science ®Google Scholar
• Shulman LP, Gabriel H. Management and localization strategies for the nonpalpable Implanon rod. Contraception 2006;73:325–330.
   PubMed Web of Science ®Google Scholar
• Mansour D, Inki P, Gemzell-Danielsson K. Efficacy of contraceptive methods: A review of the literature. Eur J Contracept Reprod Health Care 2010;15:4–16.
   PubMed Web of Science ®Google Scholar
• Gillies R, Scougall P, Nicklin S.. Etonogestrel implants - case studies of median nerve injury following removal. Aust Fam Physician 2011;40:799–800.
   PubMed Web of Science ®Google Scholar
• Darney P, Patel A, Rosen K, Shapiro LS, Kaunitz AM. Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials. Fertil Steril 2009;91:1646–1653.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists Committee on Gynecologic Practice; Long-Acting Reversible Contraception Working Group. ACOG Committee Opinion no. 450: Increasing use of contraceptive implants and intrauterine devices to reduce unintended pregnancy. Obstet Gynecol 2009;114:1434–1438.
   PubMedGoogle Scholar
• Food and Drug Administration. Second report on intrauterine contraceptive devices. Washington (DC): Food and Drug Administraction;1978.
   Google Scholar
• Funk S, Miller MM, Mishell DR Jr, Archer DF, Poindexter A, Schmidt J, Zampaglione E; Implanon US Study Group. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception 2005;71:319–326.
   PubMed Web of Science ®Google Scholar
• Mansour D, Korver T, Marintcheva-Petrova M, Fraser IS. The effects of Implanon on menstrual bleeding patterns. Eur J Contracept Reprod Health Care 2008;13 Suppl 1:13–28.
   PubMed Web of Science ®Google Scholar
• Casey PM, Long ME, Marnach ML, Bury JE.; Bleeding related to etonogestrel subdermal implant in a US population. Contraception 2011;83:426–430.
   PubMed Web of Science ®Google Scholar
• Walch K, Unfried G, Huber J, Kurz C, van Trotsenburg M, Pernicka E, Wenzl R. Implanon versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis–a pilot study. Contraception 2009;79:29–34.
   PubMed Web of Science ®Google Scholar
• Shokeir T, Amr M, Abdelshaheed M. The efficacy of Implanon for the treatment of chronic pelvic pain associated with pelvic congestion: 1-year randomized controlled pilot study. Arch Gynecol Obstet 2009;280:437–443.
   PubMed Web of Science ®Google Scholar
• Power J, French R, Cowan F. Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy. Cochrane Database Syst Rev 2007: CD001326.
   PubMed Web of Science ®Google Scholar
• Belsey EM, Machin D, d’Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction. Contraception 1986;34:253–260.
   PubMed Web of Science ®Google Scholar
• Belsey EM, Farley TM. The analysis of menstrual bleeding patterns: a review. Contraception 1988;38:129–156.
   PubMed Web of Science ®Google Scholar
• Blumenthal PD, Gemzell-Danielsson K, Marintcheva-Petrova M. Tolerability and clinical safety of Implanon. Eur J Contracept Reprod Health Care 2008;13 Suppl 1:29–36.
   PubMed Web of Science ®Google Scholar
• Abdel-Aleem H, d’Arcangues C, Vogelsong KM, Gülmezoglu AM. Treatment of vaginal bleeding irregularities induced by progestin only contraceptives. Cochrane Database Syst Rev 2007: CD003449.
   Web of Science ®Google Scholar
• Alvarez-Sanchez F, Brache V, Thevenin F, Cochon L, Faundes A. Hormonal treatment for bleeding irregularities in Norplant implant users. Am J Obstet Gynecol 1996;174:919–922.
   PubMed Web of Science ®Google Scholar
• Witjaksono J, Lau TM, Affandi B, Rogers PA. Oestrogen treatment for increased bleeding in Norplant users: preliminary results. Hum Reprod 1996;11 Suppl 2:109–114.
   PubMedGoogle Scholar
• Díaz S, Croxatto HB, Pavez M, Belhadj H, Stern J, Sivin I. Clinical assessment of treatments for prolonged bleeding in users of Norplant implants. Contraception 1990;42:97–109.
   PubMed Web of Science ®Google Scholar
• Cheng L, Zhu H, Wang A, Ren F, Chen J, Glasier A. Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel. Hum Reprod 2000;15:1969–1972.
   PubMed Web of Science ®Google Scholar
• Weisberg E, Hickey M, Palmer D, O’Connor V, Salamonsen LA, Findlay JK, Fraser IS. A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon. Hum Reprod 2006;21:295–302.
   PubMed Web of Science ®Google Scholar
• Abdel-Aleem H, Shaaban OM, Amin AF, Abdel-Aleem AM. Tamoxifen treatment of bleeding irregularities associated with Norplant use. Contraception 2005;72:432–437.
   PubMed Web of Science ®Google Scholar
• Subakir SB, Setiadi E, Affandi B, Pringgoutomo S, Freisleben HJ. Benefits of vitamin E supplementation to Norplant users–in vitro and in vivo studies. Toxicology 2000;148:173–178.
   PubMed Web of Science ®Google Scholar
• d’Arcangues C, Piaggio G, Brache V, Aissa RB, Hazelden C, Massai R, Pinol A, et al.; Study Group on Progestogen-induced Vaginal Bleeding Disturbances. Effectiveness and acceptability of vitamin E and low-dose aspirin, alone or in combination, on Norplant-induced prolonged bleeding. Contraception 2004;70:451–462.
   PubMed Web of Science ®Google Scholar
• Kaewrudee S, Taneepanichskul S, Jaisamraun U, Reinprayoon D. The effect of mefenamic acid on controlling irregular uterine bleeding secondary to Norplant use. Contraception 1999;60:25–30.
   PubMed Web of Science ®Google Scholar
• Lukes AS, Moore KA, Muse KN, Gersten JK, Hecht BR, Edlund M, Richter HE, et al. Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol 2010;116:865–875.
   PubMed Web of Science ®Google Scholar
• Weisberg E, Hickey M, Palmer D, O’Connor V, Salamonsen LA, Findlay JK, Fraser IS. A randomized controlled trial of treatment options for troublesome uterine bleeding in Implanon users. Hum Reprod 2009;24:1852–1861.
   PubMed Web of Science ®Google Scholar
• Weisberg E, Croxatto HB, Findlay JK, Burger H, Fraser IS. A randomized study of the effect of mifepristone alone or in conjunction with ethinyl estradiol on ovarian function in women using the etonogestrel-releasing subdermal implant, Implanon®. Contraception 2011;84:(6):600–8.
   PubMed Web of Science ®Google Scholar
• Bitzer J, Tschudin S, Alder J; Swiss Implanon Study Group. Acceptability and side-effects of Implanon in Switzerland: a retrospective study by the Implanon Swiss Study Group. Eur J Contracept Reprod Health Care 2004;9:278–284.
   PubMed Web of Science ®Google Scholar
• Zheng SR, Zheng HM, Qian SZ, Sang GW, Kaper RF. A long-term study of the efficacy and acceptability of a single-rod hormonal contraceptive implant (Implanon) in healthy women in China. Eur J Contracept Reprod Health Care 1999;4:85–93.
   PubMedGoogle Scholar
• Dorflinger LJ. Metabolic effects of implantable steroid contraceptives for women. Contraception 2002;65:47–62.
   PubMed Web of Science ®Google Scholar
• Merki-Feld GS, Imthurn B, Seifert B. Effects of the progestagen-only contraceptive implant Implanon on cardiovascular risk factors. Clin Endocrinol (Oxf) 2008;68:355–360.
   PubMed Web of Science ®Google Scholar
• Merki-Feld GS, Rosselli M, Imthurn B, Spanaus K. No effect of Implanon® on inflammatory cardiovascular parameters. Gynecol Endocrinol 2011;27:951–955.
   PubMed Web of Science ®Google Scholar
• Guazzelli CA, de Queiroz FT, Barbieri M, Barreiros FA, Torloni MR, Araujo FF. Metabolic effects of contraceptive implants in adolescents. Contraception 2011;84:409–412.
   PubMed Web of Science ®Google Scholar
• Biswas A, Viegas OA, Coeling Bennink HJ, Korver T, Ratnam SS. Implanon contraceptive implants: effects on carbohydrate metabolism. Contraception 2001;63:137–141.
   PubMed Web of Science ®Google Scholar
• Oderich CL, Wender MC, Lubianca JN, Santos LM, de Mello GC. Impact of etonogestrel-releasing implant and copper intrauterine device on carbohydrate metabolism: a comparative study. Contraception 2011 Sep 17.
   PubMed Web of Science ®Google Scholar
• Vieira CS, Ferriani RA, Garcia AA, Pintão MC, Azevedo GD, Gomes MK, Silva-de-Sá MF. Use of the etonogestrel-releasing implant is associated with hypoactivation of the coagulation cascade. Hum Reprod 2007;22:2196–2201.
   PubMed Web of Science ®Google Scholar
• Beerthuizen R, van Beek A, Massai R, Mäkäräinen L, Hout J, Bennink HC. Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception. Hum Reprod 2000;15:118–122.
   PubMed Web of Science ®Google Scholar
• Bahamondes L, Monteiro-Dantas C, Espejo-Arce X, Dos Santos Fernandes AM, Lui-Filho JF, Perrotti M, Petta CA. A prospective study of the forearm bone density of users of etonorgestrel- and levonorgestrel-releasing contraceptive implants. Hum Reprod 2006;21:466–470.
   PubMed Web of Science ®Google Scholar
• Morrison CS, Turner AN, Jones LB. Highly effective contraception and acquisition of HIV and other sexually transmitted infections. Best Pract Res Clin Obstet Gynaecol 2009;23:263–284.
   PubMed Web of Science ®Google Scholar
• Stringer EM, Giganti M, Carter RJ, El-Sadr W, Abrams EJ, Stringer JS; MTCT-Plus Initiative. Hormonal contraception and HIV disease progression: a multicountry cohort analysis of the MTCT-Plus Initiative. AIDS 2009;23 Suppl 1:S69–S77.
   PubMedGoogle Scholar
• Bazin B, Thevenot R, Bursaux C, Paris J. Effect of nomegestrol acetate, a new 19-nor-progesterone derivative, on pituitary-ovarian function in women. Br J Obstet Gynaecol 1987;94:1199–1204.
   PubMedGoogle Scholar
• National Institute for Health and Clinical Excellence. Long-acting reversible contraception: NICE guideline2005. Avilable at: www.nice.org.uk/CG30.
   Google Scholar
• Church E, Sengupta S, Chia KV. The contraceptive implant for long acting reversible contraception in patients undergoing first trimester medical termination of pregnancy. Sex Reprod Healthc 2010;1:105–109.
   PubMed Web of Science ®Google Scholar
• MSD. Implanon data on file, July 2010.
   Google Scholar
• IMPLANON [package insert]. Schering-Plough Corporation, 2006.
   Google Scholar
• Kittur ND, Secura GM, Peipert JF, Madden T, Finer LB, Allsworth JE. Comparison of contraceptive use between the Contraceptive CHOICE Project and state and national data. Contraception 2011;83:479–485.
   PubMed Web of Science ®Google Scholar
• Lipetz C, Phillips CJ, Fleming CF. The cost-effectiveness of a long-acting reversible contraceptive (Implanon) relative to oral contraception in a community setting. Contraception 2009;79:304–309.
   PubMed Web of Science ®Google Scholar
• Tocce K, Sheeder J, Python J, Teal SB. Long acting reversible contraception in postpartum adolescents: early initiation of etonogestrel implant is superior to IUDs in the outpatient setting. J Pediatr Adolesc Gynecol 2012;25:59–63.
   PubMed Web of Science ®Google Scholar
• Lewis LN, Doherty DA, Hickey M, Skinner SR. Implanon as a contraceptive choice for teenage mothers: a comparison of contraceptive choices, acceptability and repeat pregnancy. Contraception 2010;81:421–426.
   PubMed Web of Science ®Google Scholar
• Available at: www.Din-Link database.org (MAT Feb 2007).
   Google Scholar
• Booranabunyat S, Taneepanichskul S. Implanon use in Thai women above the age of 35 years. Contraception 2004;69:489–491.
   PubMed Web of Science ®Google Scholar
• Croxatto HB, Urbancsek J, Massai R, Coelingh Bennink H, van Beek A. A multicentre efficacy and safety study of the single contraceptive implant Implanon. Implanon Study Group. Hum Reprod 1999;14:976–981.
   PubMed Web of Science ®Google Scholar
• Flores JB, Balderas ML, Bonilla MC, Vázquez-Estrada L. Clinical experience and acceptability of the etonogestrel subdermal contraceptive implant. Int J Gynaecol Obstet 2005;90:228–233.
   PubMed Web of Science ®Google Scholar
• Lopez LM, Grimes DA, Chen-Mok M, Westhoff C, Edelman A, Helmerhorst FM. Hormonal contraceptives for contraception in overweight or obese women. Cochrane Database Syst Rev 2010: CD008452.
   Web of Science ®Google Scholar
• Medical eligibility criteria for contraceptive use. 4rd ed. WHO Library Cataloguing-in-Publication Data, World Health Organization; 2009.
   Google Scholar
• Brito MB, Ferriani RA, Quintana SM, Yazlle ME, Silva de Sá MF, Vieira CS. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study. Contraception 2009;80:519–526.
   PubMed Web of Science ®Google Scholar
• Taneepanichskul S, Reinprayoon D, Thaithumyanon P, Praisuwanna P, Tosukhowong P, Dieben T. Effects of the etonogestrel-releasing implant Implanon and a nonmedicated intrauterine device on the growth of breast-fed infants. Contraception 2006;73:368–371.
   PubMed Web of Science ®Google Scholar
• Gurtcheff SE, Turok DK, Stoddard G, Murphy PA, Gibson M, Jones KP. Lactogenesis after early postpartum use of the contraceptive implant: a randomized controlled trial. Obstet Gynecol 2011;117:1114–1121.
   PubMed Web of Science ®Google Scholar
• Yonkers KA, O’Brien PM, Eriksson E. Premenstrual syndrome. Lancet 2008;371:1200–1210.
   PubMed Web of Science ®Google Scholar
• Rosenberg MJ, Waugh MS, Burnhill MS. Compliance, counseling and satisfaction with oral contraceptives: a prospective evaluation. Fam Plann Perspect 1998;30:89–92.
   PubMedGoogle Scholar
• Leticee N, Viard JP, Yamgnane A, Karmochkine M, Benachi A. Contraceptive failure of etonogestrel implant in patients treated with antiretrovirals including efavirenz. Contraception 2011 Oct 27.
   PubMed Web of Science ®Google Scholar